BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38184401)

  • 1. Second Malignancy Probabilities in Patients With Breast Cancer Treated With Conventional Versus Hypofractionated External Beam Radiation Therapy in the Adjuvant Setting.
    Patel TA; Jain B; Cho HL; Corti C; Vapiwala N; Chino F; Leeman JE; Dee EC
    Clin Oncol (R Coll Radiol); 2024 Mar; 36(3):183-192. PubMed ID: 38184401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality.
    Dee EC; Taunk NK; Chino FL; Deville C; McClelland S; Muralidhar V; McBride SN; Gillespie EF; Yamoah K; Nguyen PL; Mahal BA; Winkfield KM; Vapiwala N; Santos PMG
    JCO Oncol Pract; 2023 Feb; 19(2):e197-e212. PubMed ID: 36399692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy.
    Obedian E; Fischer DB; Haffty BG
    J Clin Oncol; 2000 Jun; 18(12):2406-12. PubMed ID: 10856100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Outcomes of Post-mastectomy Breast Cancer Patients Treated with Hypofractionated Radiation Treatment Compared to Conventional Fractionation -a Retrospective Cohort Study.
    Raveendran C; Meloot SS; Yadev I
    Gulf J Oncolog; 2023 May; 1(42):26-34. PubMed ID: 37283257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
    Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma.
    Zablotska LB; Neugut AI
    Cancer; 2003 Mar; 97(6):1404-11. PubMed ID: 12627503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Hypofractionated Versus Conventional Fractionated Postmastectomy Radiation Therapy in Breast Cancer Patients  With Reconstruction.
    Kim DY; Park E; Heo CY; Jin US; Kim EK; Han W; Shin KH; Kim IA
    Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):445-456. PubMed ID: 34610389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes Following a Moderately Hypofractionated Adjuvant Radiation (START B Type) Schedule for Breast Cancer in an Unscreened Non-Caucasian Population.
    Chatterjee S; Arunsingh M; Agrawal S; Dabkara D; Mahata A; Arun I; Shrimali RK; Achari R; Mallick I; Ahmed R
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):e165-72. PubMed ID: 27369459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis.
    Kim DY; Park E; Heo CY; Jin US; Kim EK; Han W; Shin KH; Kim IA
    Breast; 2021 Feb; 55():37-44. PubMed ID: 33316582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignancy in young early-stage breast cancer patients with modern radiotherapy: A long-term population-based study (A STROBE-compliant study).
    Xie L; Lin C; Zhang H; Bao X
    Medicine (Baltimore); 2018 Apr; 97(17):e0593. PubMed ID: 29703057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis.
    Botrel TE; Clark O; Pompeo AC; Bretas FF; Sadi MV; Ferreira U; Dos Reis RB
    Core Evid; 2013; 8():1-13. PubMed ID: 23526383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk.
    Fowble B; Hanlon A; Freedman G; Nicolaou N; Anderson P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):679-90. PubMed ID: 11597809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.
    Hong Z; Yang Z; Mei X; Li P; Bao C; Wang Z; Cai X; Ming X; Wang W; Guo X; Yu X; Zhang Q
    Radiat Oncol; 2023 Mar; 18(1):56. PubMed ID: 36959653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
    Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R
    Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second malignancy probabilities in patients with prostate cancer treated with whole pelvis radiation therapy versus prostate only radiation therapy.
    Cho HL; Murthy V; Mouw KW; D'Amico AV; Nguyen PL; Leeman JE; Dee EC
    Prostate; 2022 Aug; 82(11):1098-1106. PubMed ID: 35652585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
    Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM;
    Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?
    Hamilton SN; Tyldesley S; Li D; Olson R; McBride M
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):977-85. PubMed ID: 25832690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the risk of secondary lung malignancies associated with whole-breast radiation therapy.
    Ng J; Shuryak I; Xu Y; Clifford Chao KS; Brenner DJ; Burri RJ
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1101-6. PubMed ID: 22245205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results.
    Burt LM; Ying J; Poppe MM; Suneja G; Gaffney DK
    Breast; 2017 Oct; 35():122-129. PubMed ID: 28719811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second cancer, breast cancer, and cardiac mortality in stage T1aN0 breast cancer patients with or without external beam radiation therapy: a national registry study.
    Ye JC; Yan W; Christos P; Nori D; Chao KS; Ravi A
    Clin Breast Cancer; 2015 Feb; 15(1):54-9. PubMed ID: 25223278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.